First fully indigenous vaccine shows ‘near-complete protection’ from Covid
The IMTECH team used the SARS-CoV-2 spike protein — one of four structural proteins encoded in the virus that is the major virulence factor enabling pathogens to infect the host (human) and stabilised it to use as the antigen IMT-CVAX. It elicited robust anti-spike IgG antibodies in mice, effectively neutralising various virus variants, including Delta, …